Stock Research: MEDNAX

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

MEDNAX

NYSE:MD US58502B1061
70
  • Value
    75
  • Growth
    39
  • Safety
    Safety
    71
  • Combined
    82
  • Sentiment
    53
  • 360° View
    360° View
    70
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Pediatrix Medical Group, Inc. provides physician services specializing in newborn, maternal-fetal, and pediatric subspecialty care across various hospital settings and office-based practices. Their main businesses include obstetrics, maternal-fetal medicine, neonatology, and other pediatric subspecialties. In the last fiscal year, the company had 2150 employees, a market cap of $1100 million, profits of NULL, and revenue of $2013 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 70 (better than 70% compared with alternatives), overall professional sentiment and financial characteristics for the stock MEDNAX are above average. The 360° View is based on consolidating four consolidated indicators, with half of the indicators below and half above average for MEDNAX. The consolidated Value Rank has an attractive rank of 71, which means that the share price of MEDNAX is on the lower side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 71% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 75. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 53. But the consolidated Growth Rank has a low rank of 39, which means that the company is below average in terms of growth and momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. 61 of its competitors have better growth. ...read more

more
Index
D.J. US Health Care
S&P MIDCAP
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
71 76 84 50
Growth
39 29 19 67
Safety
Safety
75 74 73 43
Sentiment
53 34 4 29
360° View
360° View
70 61 38 39
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
24 36 7 9
Opinions Change
50 50 31 50
Pro Holdings
n/a 58 14 75
Market Pulse
82 17 11 32
Sentiment
53 34 4 29
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
71 76 84 50
Growth
39 29 19 67
Safety Safety
75 74 73 43
Combined
82 81 76 55
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
91 94 97 57
Price vs. Earnings (P/E)
54 67 74 53
Price vs. Book (P/B)
58 61 83 51
Dividend Yield
1 1 1 1
Value
71 76 84 50
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
18 10 25 32
Profit Growth
58 44 20 76
Capital Growth
24 20 64 64
Stock Returns
83 89 7 65
Growth
39 29 19 67
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
49 55 44 24
Refinancing
77 65 60 67
Liquidity
60 46 57 37
Safety Safety
75 74 73 43

Similar Stocks

Discover high‑ranked alternatives to MEDNAX and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Intuit

NasdaqGS:INTU
Country: USA
Industry: Application Software
Size: X-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.